Non-Invasive, Liquid Biopsies with Real-Time Monitoring.
Early Detection Saves Lives.
At DCan Biosciences our purpose is to transform how cancer is detected, monitored, and managed through advanced, non-invasive blood tests known as liquid biopsies. We aim to give patients and clinicians clearer, more meaningful insights into the disease — without the need for invasive tissue biopsies.
What is a Liquid Biopsy?
A medical test that analyzes molecular changes in blood, urine, or other body fluids. Unlike traditional tissue biopsies, which require surgically removing a piece of a tumor, liquid biopsies provide a less invasive way to capture vital information through circulating biomarkers.
Liquid biopsies can analyze
Circulating Tumor Cells (CTCs)
small fragments of DNA shed by tumors.
Circulating Tumor DNA (ctDNA)
intact cancer cells released into the bloodstream, considered the “seeds” of metastasis.
Exosomes
small vesicles released by tumors that play a role in cancer progression.
Other Biomarkers
such as proteins.
Liquid Biopsies Enable Us to
Detect Cancer Early
We can identify tumors at earlier, more treatable stages.
Genetic Profiling
We can identify tumor mutations and therapeutic targets, guiding precision medicine.
MRD Monitoring
We can detect small amounts of cancer that remain after treatment.
Subscribe to be the first to know about our full launch.
HOME
SERVICES
TEAM
ABOUT US
DCan Biosciences